medigraphic.com
SPANISH

Archivos de Investigación Materno Infantil

ISSN 2007-3194 (Print)
Órgano de difusión oficial del Instituto Materno Infantil del Estado de México
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2011, Number 1

Next >>

Arch Inv Mat Inf 2011; 3 (1)

Hiperplasia suprarrenal congénita por deficiencia de 21-hidroxilasa. Reporte de un caso

Bobadilla MOPV, Demesa AR, Valdés LA, García RJF, Núñez HJA
Full text How to cite this article

Language: Spanish
References: 8
Page: 3-8
PDF size: 266.03 Kb.


Key words:

Suprarenal hyperplasia, deficiency of 21-hydroxylase, wasting salt variety, adrenal crisis, fludrocortisone.

ABSTRACT

The congenital adrenal hyperplasia it produced by autosomical recessive disorders in the cortisol and aldosterone synthesis, includes five different enzymatic disorders; the most common is due to deficiency of 21-hydroxylase (90-95%), with an incidence of 1 in 20,000 births in the classical variety. Classical congenital adrenal hyperplasia due to wasting salt variety usually initiate with a clinical picture at 7 or 14 days of life with an adrenal crisis characterized by hyponatremia, hyperkalemia and hypoglycemia. The diagnostic gold standard for neonatal screening is possible by detection of persistently elevated 17-hydroxyprogesterone. Current treatment of classic congenital adrenal hyperplasia aims to provide adequate glucocorticoid and, when necessary, mineralocorticoid substitution to prevent adrenal crises and to suppress the excessive secretion of CRH and ACTH, thereby reducing circulating concentrations of adrenal androgens and steroid precursor.


REFERENCES

  1. Amaro-Méndez S. Breve historia de la endocrinología. Científico-Médica. Cuba, 1975.

  2. Merke D, Bornstein S. Congenital adrenal hyperplasia. The Lancet 2005; 365: 2125-2133.

  3. Claahsen-van der Grinten H, et al. Prevalence of testicular adrenal rest tumours in male children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. European Journal of Endocrinology 2007; 157: 339-344.

  4. Steagani M. Hiperplasia suprarrenal congénita: experiencia de 30 años. Rev de Cir Infantil 2000; 10 (1): 1-10.

  5. Charmandari E, et al. Classic congenital adrenal hyperplasia and puberty. European Journal of Endocrinology 2004; 151: 77-82.

  6. Charmandari E, et al. Congenital adrenal hyperplasia: Management during critical illness. Archives of Disease in Childhood 2001; 85 (1): 26-28.

  7. New M. Diagnosis and management of congenital adrenal hyperplasia. Annual Review of Medicine 1998; 49: 311-328.

  8. Cos-Welsh S, Flores-Lozano F, Cabeza-Gómez A. Padecimientos de la corteza suprarrenal. Temas de Pediatría, Asociación Mexicana de Pediatría, A.C. Endocrinología, McGraw-Hill Interamericana, 1998: 161-184.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Arch Inv Mat Inf. 2011;3